fda 503a bulks list peptides bpc-157 Exciting news for coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- 157 to the for use in compounding for HIMS is up nearly 8%
HIMS is up nearly 8% after FDA advisers voted to recommend adding BPC 157 to the 503A Bulks List. A major win for the peptide market. 83% of peptide aware Americans want the FDA to make peptides more accessible $HIMS Stock: FDA Panel Recommends BPC 157 Peptide peptidemedicine #fda #503a #compounding American Academy of Peptide Medicine
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


